Arrowstreet Capital’s Codexis CDXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-17,900
Closed -$416K 1467
2021
Q3
$416K Buy
+17,900
New +$424K ﹤0.01% 1442
2020
Q4
Sell
-28,702
Closed -$337K 2306
2020
Q3
$337K Buy
+28,702
New +$358K ﹤0.01% 2118
2017
Q3
Sell
-26,639
Closed -$145K 1111
2017
Q2
$145K Sell
26,639
-10,300
-28% -$47.4K ﹤0.01% 1017
2017
Q1
$177K Buy
+36,939
New +$168K ﹤0.01% 1209
2016
Q4
Sell
-36,939
Closed -$164K 1748
2016
Q3
$164K Buy
+36,939
New +$155K ﹤0.01% 1438

Other funds holding CDXS

Arrowstreet Capital's CDXS Position: Q4 2021 in Review

Arrowstreet Capital sold out of Codexis (CDXS) in Q4 2021, closing a stake of 17,900 shares — an estimated $416K sold.

Arrowstreet Capital first reported a position in CDXS in Q3 2016 and held it in 5 quarters. The position peaked at $416K in Q3 2021. 177 funds tracked by Wall St. Rank hold CDXS as of Q4 2021.

  • Arrowstreet Capital reported no remaining Codexis position as of Q4 2021 after selling out during the quarter.
  • Arrowstreet Capital sold 17,900 Codexis shares in Q4 2021, an estimated $416K.
  • Arrowstreet Capital first reported a position in Codexis in Q3 2016 and held it in 5 quarters.
  • Arrowstreet Capital's Codexis position peaked at $416K in Q3 2021.
  • 177 funds tracked by Wall St. Rank held Codexis as of Q4 2021.

Based on Arrowstreet Capital's 13F filing for Q4 2021, filed 14 Feb 2022.